Net Cash Provided by (Used in) Operating Activities |
-19.7K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
400K |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Common Stock, Shares Authorized |
350M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
49M |
shares |
-41.7% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-19.7K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
645K |
USD |
+23.8% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
645K |
USD |
+23.8% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Issued |
300K |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Additional Paid in Capital |
3.9M |
USD |
+77.3% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Outstanding |
300K |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |